Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature
- PMID: 35355299
- DOI: 10.1111/cup.14235
Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature
Abstract
Cutaneous leukocytoclastic vasculitis (LCV) has been reported as a rare form of cutaneous reaction to different SARS-Cov-2 vaccines. Herein, we present the first case of cutaneous LCV following BBIBP-CorV (Sinopharm) vaccine that occurred in a female patient with no prior comorbidities. A literature review about similar cases following different COVID-19 vaccines is discussed.
Keywords: BBIBP-CorV vaccine; COVID vaccine; Sinopharm; vasculitis.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Micheletti RG, Werth VP. Small vessel vasculitis of the skin. Rheum Dis Clin North Am. 2015;41(1):21-vii.
-
- Frumholtz L, Laurent-Roussel S, Lipsker D, Terrier B. Cutaneous vasculitis: review on diagnosis and clinicopathologic correlations. Clin Rev Allergy Immunol. 2021;61(2):181-193.
-
- Pillebout E, Sunderkötter C. IgA vasculitis. Semin Immunopathol. 2021;43(5):729-738.
-
- Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798-806.
-
- Sandhu S, Chand S, Bhatnagar A, et al. Possible association between IgA vasculitis and COVID-19. Dermatol Ther. 2021;34(1):e14551.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
